Company Name: Pieris Pharmaceuticals, Inc.
Pieris Pharmaceuticals, Inc. is a clinical stage biotechnology company. The company is engaged in the discovery and development of Anticalin-based therapeutics using its proprietary Anticalin® technology. The company’s developmental pipeline includes product candidates for anemia, asthma and immuno-oncology. In addition to developing its proprietary programs, the company also collaborates with other companies.
Ticker Symbol: PIRS (NASDAQ)
Company Website: www.pieris.com
Headquarters: Boston, MA